Tiago Machuca

Papers

Total Citations

H-Index

About

Tiago Machuca is a leading thoracic surgeon and researcher whose work is transforming the surgical management of early-stage lung cancer. His primary research focus is on minimally invasive thoracic oncology, with a particular emphasis on comparing the clinical and economic outcomes of robotic-assisted and video-assisted thoracoscopic surgery (VATS). Machuca’s major contribution lies in rigorously evaluating the cost-effectiveness and patient-centered benefits of robotic lobectomy. His landmark 2023 study, which has garnered 53 citations, provides compelling evidence that robotic lobectomy is not only cost-effective but also delivers comparable health utility scores to VATS, challenging assumptions about the economic viability of robotic platforms. He is also the principal architect of the RAVAL trial (24 citations), an international, multi-centered, blinded randomized controlled trial designed to definitively compare robotic-assisted versus video-assisted lobectomy. This protocol represents a pivotal step toward establishing evidence-based guidelines for surgical approach selection. Machuca’s work is highly influential, directly shaping clinical practice and hospital resource allocation by demonstrating that advanced robotic technology can be both economically sustainable and beneficial for patient recovery. His research is essential reading for anyone interested in the future of thoracic surgery and the integration of health economics into surgical decision-making.